NCT04185883 2025-10-22
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Amgen
Phase 1 Active not recruiting
Amgen
Oncovir, Inc.
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)